Literature DB >> 12165988

Oral candidosis.

Robert G Sherman1, Leo Prusinski, Michele Carter Ravenel, Richard A Joralmon.   

Abstract

Oral candidosis is the most common opportunistic fungal infection encountered in dentistry. Normally a benign inhabitant of mucous membranes, the fungal organism, Candida albicans, may present serious, even life-threatening infection in specific patient populations. As an opportunistic organism, Candida albicans is extremely responsive to any process resulting in immunosuppression. The clinical manifestations of oral candidosis are variable, occasionally complicating the clinical diagnosis and management. Treatment is often initially rendered based on a provisional clinical diagnosis and supplemented with adjunctive laboratory tests. Specific therapeutic intervention should be tailored to the individual patient, based on the current health status of the patient and the clinical presentation and severity of the infection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12165988

Source DB:  PubMed          Journal:  Quintessence Int        ISSN: 0033-6572            Impact factor:   1.677


  9 in total

1.  The role of Candida albicans hyphae and Lactobacillus in denture-related stomatitis.

Authors:  Hakan Bilhan; Tonguç Sulun; Gonca Erkose; Hanefi Kurt; Zayre Erturan; Omer Kutay; Tayfun Bilgin
Journal:  Clin Oral Investig       Date:  2008-12-20       Impact factor: 3.573

2.  Surgical management of chronic hyperplastic candidiasis refractory to systemic antifungal treatment.

Authors:  Neha Shah; Jay Gopal Ray; Sanchita Kundu; Divesh Sardana
Journal:  J Lab Physicians       Date:  2017 Apr-Jun

Review 3.  Oral mycobiome identification in atopic dermatitis, leukemia, and HIV patients - a systematic review.

Authors:  Camila Stofella Sodré; Paulo Matheus Guerra Rodrigues; Mayra Stambovsky Vieira; Alexandre Marques Paes da Silva; Lucio Souza Gonçalves; Marcia Gonçalves Ribeiro; Dennis de Carvalho Ferreira
Journal:  J Oral Microbiol       Date:  2020-08-17       Impact factor: 5.474

4.  Oral candidal carriage and its association with dental carious lesions in asymptomatic adults: a cross-sectional study from the UAE.

Authors:  Suhail H Al-Amad; Betul Rahman; Nadia Khalifa; Manal A Awad
Journal:  BMC Oral Health       Date:  2021-04-19       Impact factor: 2.757

5.  Efficacy of clotrimazole for the management of oral candidiasis: A meta-analysis of randomized clinical trials.

Authors:  Thamer A Almangour; Keith S Kaye; Mohammed Alessa; Khalid Eljaaly; Fadilah Sfouq Aleanizy; Aynaa Alsharidi; Fahad M Al Majid; Naif H Alotaibi; Abdullah A Alzeer; Faris S Alnezary; Abdullah A Alhifany
Journal:  Saudi Pharm J       Date:  2021-03-24       Impact factor: 4.330

6.  An underestimated pitfall of oral candidiasis in head and neck cancer patients undergoing radiotherapy: an observation study.

Authors:  Imjai Chitapanarux; Somying Wongsrita; Patumrat Sripan; Panithan Kongsupapsiri; Panchalee Phakoetsuk; Siriarrayapa Chachvarat; Kittikun Kittidachanan
Journal:  BMC Oral Health       Date:  2021-07-16       Impact factor: 2.757

7.  Vinegar as an antimicrobial agent for control of Candida spp. in complete denture wearers.

Authors:  Telma Maria Silva Pinto; Ana Christina Claro Neves; Mariella Vieira Pereira Leão; Antonio Olavo Cardoso Jorge
Journal:  J Appl Oral Sci       Date:  2008 Nov-Dec       Impact factor: 2.698

Review 8.  Clinical Appearance of Oral Candida Infection and Therapeutic Strategies.

Authors:  Shankargouda Patil; Roopa S Rao; Barnali Majumdar; Sukumaran Anil
Journal:  Front Microbiol       Date:  2015-12-17       Impact factor: 5.640

9.  Effect of the Ethyl Acetate Fraction of Eugenia uniflora on Proteins Global Expression during Morphogenesis in Candida albicans.

Authors:  Walicyranison P Silva-Rocha; Matheus F de Azevedo; Magda R A Ferreira; Julhiany de Fátima da Silva; Terezinha I E Svidzinski; Eveline P Milan; Luiz A L Soares; Keyla B F Rocha; Adriana F Uchôa; Maria J S Mendes-Giannini; Ana M Fusco Almeida; Guilherme M Chaves
Journal:  Front Microbiol       Date:  2017-09-26       Impact factor: 5.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.